India vaccine Coronavirus Fighting India

Booster dose of Covid vaccine needed to fight against Omicron variant: NIV

Reading now: 731
www.livemint.com

Covid vaccines showed a very good neutralising antibody response against Delta and other Variants of Concern. However, with regard to the Omicron variant of coronavirus, there was a reduction seen in neutralizing antibody levels in all cohorts (Covishield + Covaxin; Covaxin +Covaxin and Covishield + Covishield). "The gradual shift of VoCs from Delta to Delta-sub-lineage to Omicron, along with the observed waning of immunity post six months of vaccination, has prompted discourses around devising an innovative vaccination strategy.

The present investigation findings contribute meaningfully to such discussions. Regardless of the findings of this study, longitudinal monitoring for breakthrough infections should remain a part of any surveillance system," the study stated.

India began administering the precaution doses of the Covid-19 vaccines to the healthcare and frontline workers and those aged 60 years and above with comorbidities from January 10.

The Union health ministry removed the comorbidity clause recently, making everyone aged above 60 years eligible for the precaution dose of the Covid vaccines.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

New deadly side effect warning issued to those with Covid in the last six months - dailystar.co.uk - Sweden
dailystar.co.uk
76%
915
New deadly side effect warning issued to those with Covid in the last six months
Covid in the last six months could be at risk of a deadly side effect.People who caught the virus less than half a year ago could be more likely to get blood clots, with researchers in Sweden discovering a risk of deep vein thrombosis up to three months post-infection.The research also found that people with Covid in the last six months were more susceptible to a blood clot in the lungs.Reports also indicate that there is a greater chance of a "bleeding event" in the two months after being ill.The new research from Swedish provided more evidence to the vital use of vaccines to protect from Covid complications, which aren't limited when infected with the virus.Experts found that even mild, non-hospitalised Covid patients could be at risk of potentially deadly deep vein thrombosis and pulmonary embolism.They said: "Our findings arguably support thromboprophylaxis to avoid thrombotic events, especially for high risk patients, and strengthen the importance of vaccination against Covid-19."The chances of getting a blood clot were found to be higher during the first wave of the pandemic, which suggests improvements in treatment and wide-ranging vaccine coverage has lessened the risk.Researchers at the University of Glasgow looked into "living with Covid" as more governments ease restrictions.The researchers said the study "reminds us of the need to remain vigilant to the complications associated with even mild SARS-CoV-2 infection, including thromboembolism".Deep vein thrombosis (DVT) occurs when a blood clot forms on a deep vein, usually in your legs, and if the blood clot breaks off and travels into the lungs, it can cause a potentially fatal pulmonary embolism.
DMCA